[Fetal erythroblastosis in Kell incompatibility].

Area of Science:

• Immunology
• Hematology
• Obstetrics

Background:

• Increasing prevalence of irregular antibodies due to widespread blood transfusions.
• Kell blood group system antibodies pose a risk for transfusion reactions and hemolytic disease of the fetus and newborn.
• Previous sensitization can occur through blood transfusions, leading to alloimmunization.

Observation:

• A case study documented intrauterine death resulting from Kell erythroblastosis.
• Sensitization occurred following the administration of Kell-positive banked blood.
• The indirect Coombs' test is essential for detecting Kell antibodies.

Findings:

• Kell erythroblastosis can lead to severe fetal complications, including intrauterine fetal demise.
• Proactive screening for Kell antibodies in women of childbearing age is vital.
• The enzyme test serves as a supplementary, not sole, method for antibody detection.

Implications:

• Implementing Kell system screening in blood donor selection for women of childbearing age can prevent alloimmunization.
• Routine antibody screening, including Kell antibodies, is recommended for pregnant women at risk.
• Close monitoring of sensitized pregnant women through titer follow-ups, amniocentesis, and ultrasonography is critical for fetal well-being.